Phytopharmacological potential of Wrightia tinctoria R. Br.: A promising herbal approach for the management of Psoriasis

Psoriasis is a neutrophil dermatitis and the most common habitual seditious autoimmune complaint of the skin. According to the World Health Organization (WHO), it affects 1.5 to 5% of the population in developing countries and 0.9 to 11.4% worldwide. Grounded on the extent of inflammation, it has been set up that obscenity (shrine) occurs in roughly 85- 90% of cases with psoriasis. The use of herbal drugs has endured an upsurge in recent times due to the limited side goods compared to chemical drugs. The future of developing new treatments for psoriasis lies in natural phytonutrients using ultramodern technology and innovative exploration. Wrightia tinctoria is one of the well-known implicit medicinal shops whose leaves are traditionally used to treat psoriasis and seditious dermatitis in the Buddha and Ayurvedic drug system, belonging to the family Apocynaceae. This condiment helps treat dandruff as well as colorful crown and skin conditions. Pharmacological studies on the different corridors of the factory have shown colorful remedial goods similar to antitumor, antiulcer, antidandruff, antifungal, antibacterial, anti-inflammatory, and mending goods. Primary phytochemical analysis of Wrightia tinctoria splint excerpt revealed the presence of alkaloids, glycosides, flavonoids and saponins. Wrightia tinctoria is an extensively cited medicine used to treat psoriasis.